Table 2.

Inhibition of tPA activity in cerebellar homogenates after infusions of either PAI-1 or ACSF

tPA activity remaining
Training day 2 Training day 6 Training day 9
PAI-1 infused 0.48 ± 0.2 IUa 2.67 ± 0.3 IU 3.0 ± 0.4 IU
ACSF infused 2.15 ± 0.1 IU 2.38 ± 0.3 IU 2.15 ± 0.6 IU
  • a Significantly different from ACSF infused, p < 0.01.